FloodLAMP COVID-19 Diagnostic Rights of Reference Report COVID-19 diagnostic rights of reference report analyzing public, broad, and private rights of reference in the FDA EUA ecosystem, with primary focus on Quantigen Biosciences' specimen-collection stability data. Identifies four broad/public COVID-era RoRs (CDC assay, CDC Flu SC2, Quantigen swab stability, Emory/CHOA pediatric self-swab), documents widespread reuse of Quantigen's RoR across unrelated sponsors, and distinguishes broad/public RoRs from private bilateral and master-file-based arrangements. ai file regulatory open-euas _AI_COVID_Rights_of_Reference_Report.md regulatory/open-euas/_AI_covid_rights_of_reference_report.md 2026_03_20 Created by [model not specified by user] during archive preparation. **NOT HUMAN VERIFIED - MAY CONTAIN ERRORS** Analysis of public, broad, and private rights of reference in the COVID-19 FDA EUA ecosystem, with primary focus on Quantigen Biosciences' specimen-collection stability data. Key sources include FDA COVID-19 test development FAQ, FDA EUA summaries, FDA virtual town hall transcript, user-supplied Gates Foundation presentation, and Padgett et al. PLOS ONE paper. rights-of-reference, quantigen, fda-eua, specimen-collection, gates-foundation, cdc-test, audere, swab-stability md CC BY 4.0 - https://creativecommons.org/licenses/by/4.0/ 3516 5611 gfile-url xfile-github-download-url pdf-gdrive-url pdf-github-url github-markdown-url github-markdown-download-url web-pdf-url web-slides-url youtube-url web-url